Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression in the T47D Breast Cancer Cell Line - Results of Real Time Quantitative PCR |
Ghasemali, Samaneh
(Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences)
Nejati-Koshki, Kazem (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Akbarzadeh, Abolfazl (Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Tafsiri, Elham (Biotechnology Research Center, Molecular Medicine Department, Pasteur Institute of Iran) Zarghami, Nosratollah (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Rahmati-Yamchi, Mohamad (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Alizadeh, Effat (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Barkhordari, Amin (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Tozihi, Majid (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) Kordi, Shirafkan (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences) |
1 | Atwood JL, Davies JED, MacNicol DD, et al (1996). Comprehensive Supramolecular Chemistry. Oxford Pergamon, 1-10. |
2 | Cui SH (2006). Curcumin inhibits telomerase activity in human cancer cell lines. Int J Mol Med, 18, 227-31. |
3 | Del Valle EMM (2004). Cyclodextrins and their uses: a review. Process Biochem, 39, 1033-46. DOI ScienceOn |
4 | Feng J, Funk WD, Wang SS, et al (1995). The RNA component of human telomerase. Science, 269, 1236-41. DOI ScienceOn |
5 | Hahn WC, Stewart SA, Brooks MW, et al (1999). Inhibition of telomerase limits the growth of human cancer cells. Nat Med, 5, 1164-70. DOI ScienceOn |
6 | Herbet B, Wright WE, Shaly J (2001). Telomerase and breast cancer. Breast cancer Res, 3, 146-9. DOI |
7 | Huang PR, Yeh YM, V Wang TC (2005). Potent inhibition of human telomerase by Helenalin. Cancer Lett, 227, 169-74. DOI ScienceOn |
8 | Hsina I, Sheua G, Chena H, et al (2010). N-acetyle cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of SP1 reduction in A549 cells. Mut Res, 688, 72-7. DOI ScienceOn |
9 | Jurenka J (2009). Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research. Alter Med Rev, 14, 141-52. |
10 | Kirkpatrick KL, Newbold RF, Mokbel k (2004). The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. J Carcinogenesis, 147, 3-1. |
11 | Kirkpatrick KL, Ogunkolade W, Elkak AE, et al (2003). hTERT expression in human breast cancer and noncancerous breast tissue: correlation withtumor stage and c-Myc expression. Breast Cancer Res. Treatment, 77, 277-84. |
12 | Kondo S, Kondo Y, Li G, et al (1998). Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA, Oncogene. Genes Dev, 16, 3323-30. |
13 | Lyss G, Knorre A, Schmidt TJ, et al (1998). The anti-inflammatory sesquiterpene lactone Helenalin inhibits the transcription factor NF-kappa B by directly targeting p65. J Biol Chem, 273, 33508-16. DOI ScienceOn |
14 | Mokbel K (2000). The role of telomerase in breast cancer. Eur J Surg Onco, 26, 509-14. DOI ScienceOn |
15 |
Murali MY, Jaggi S, Chauhan C (2010). |
16 | Nasiri M, Zarghami N, Koshki KN, et al (2013). Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac J Cancer Prev, 14, 3449-53. DOI ScienceOn |
17 | Saretzki G (2003). Telomerase inhibition as cancer therapy. Cancer Lett, 194, 209-19. DOI ScienceOn |
18 | Schramm G, Surmann EM, Wiesberg S, et al (2010). Analyzing the regulation of metabolic pathways in human breast cancer. BMC Medical Genomics, 2, 3-5. |
19 |
Seidel RW, Koleva BB (2009). |
20 | Shay JW, Gazdar AF (1997). Telomerase in the early detection of cancer. J Clin Pathol, 50, 106-9. DOI |
21 | Tian N, Gaines WJ, Benjamin ZF (2010). Female breast cancermortality clusters within racial groups in the United States. Health Place, 16, 209-18. DOI ScienceOn |
22 | Torkanyi I, Aradi J (2008). Pharmacological intervention strategies for affecting telomerase activity. Future prospects to treat cancer and degenerative disease. Biochimie, 90, 156-72. DOI ScienceOn |
23 | Tyagi AK, Agarwal C, Chan DCF, et al (2003). Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep, 11, 493-99. |
24 | Vivek RY, Sarasija S, Kshama D, et al (2009). Effect of Cyclodextrin complexation of curcumin on its solubility and antiangiogenic sand anti-inflammatory activity in rat colitis model. AAPS. Pharm Sci Tech, 10, 233-44. |
25 | Zhang X, Mar V, Zhou W, et al (1999). Telomere shortening and apoptosis, in telomerase-inhibited human tumor cells. Genes Dev, 13, 2388-99. DOI ScienceOn |
![]() |